JP2016506366A5 - - Google Patents

Download PDF

Info

Publication number
JP2016506366A5
JP2016506366A5 JP2015541857A JP2015541857A JP2016506366A5 JP 2016506366 A5 JP2016506366 A5 JP 2016506366A5 JP 2015541857 A JP2015541857 A JP 2015541857A JP 2015541857 A JP2015541857 A JP 2015541857A JP 2016506366 A5 JP2016506366 A5 JP 2016506366A5
Authority
JP
Japan
Prior art keywords
insulin
wild
prior
patent document
documents cited
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015541857A
Other languages
English (en)
Japanese (ja)
Other versions
JP6584953B2 (ja
JP2016506366A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/068585 external-priority patent/WO2014071405A2/en
Publication of JP2016506366A publication Critical patent/JP2016506366A/ja
Publication of JP2016506366A5 publication Critical patent/JP2016506366A5/ja
Application granted granted Critical
Publication of JP6584953B2 publication Critical patent/JP6584953B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015541857A 2012-11-05 2013-11-05 長時間作用型単鎖インスリン類似体 Expired - Fee Related JP6584953B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261722350P 2012-11-05 2012-11-05
US61/722,350 2012-11-05
PCT/US2013/068585 WO2014071405A2 (en) 2012-11-05 2013-11-05 Long-acting single-chain insulin analogues

Publications (3)

Publication Number Publication Date
JP2016506366A JP2016506366A (ja) 2016-03-03
JP2016506366A5 true JP2016506366A5 (cg-RX-API-DMAC7.html) 2016-12-15
JP6584953B2 JP6584953B2 (ja) 2019-10-02

Family

ID=50628271

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015541857A Expired - Fee Related JP6584953B2 (ja) 2012-11-05 2013-11-05 長時間作用型単鎖インスリン類似体

Country Status (15)

Country Link
US (2) US9499600B2 (cg-RX-API-DMAC7.html)
EP (1) EP2914620B1 (cg-RX-API-DMAC7.html)
JP (1) JP6584953B2 (cg-RX-API-DMAC7.html)
KR (1) KR102163936B1 (cg-RX-API-DMAC7.html)
CN (2) CN105008395B (cg-RX-API-DMAC7.html)
AU (1) AU2013337250B2 (cg-RX-API-DMAC7.html)
BR (1) BR112015010194B1 (cg-RX-API-DMAC7.html)
CA (1) CA2890719C (cg-RX-API-DMAC7.html)
EA (1) EA201590882A1 (cg-RX-API-DMAC7.html)
ES (1) ES2694418T3 (cg-RX-API-DMAC7.html)
IL (1) IL238651B (cg-RX-API-DMAC7.html)
MX (1) MX2015005662A (cg-RX-API-DMAC7.html)
PH (1) PH12015500989A1 (cg-RX-API-DMAC7.html)
SG (1) SG11201503522RA (cg-RX-API-DMAC7.html)
WO (1) WO2014071405A2 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2877200B1 (en) * 2012-07-17 2019-05-08 Case Western Reserve University O-linked carbohydrate-modified insulin analogues
US9624287B2 (en) 2012-07-17 2017-04-18 Case Western Reserve University O-linked carbohydrate-modified insulin analogues
CN106102763A (zh) 2014-01-13 2016-11-09 塞尔玛琳糖尿病有限责任公司 速效胰岛素制剂和药物递送系统
CZ308383B6 (cs) * 2014-06-30 2020-07-15 Ústav Organické Chemie A Biochemie Akademie Věd Čr, V.V.I. Derivát inzulinu s cyklickou strukturou v C-konci B-řetězce
KR102569743B1 (ko) * 2014-10-06 2023-08-23 케이스 웨스턴 리저브 유니버시티 이상 단일 사슬 인슐린 유사체
AR105616A1 (es) 2015-05-07 2017-10-25 Lilly Co Eli Proteínas de fusión
HK1255634A1 (zh) * 2015-12-23 2019-08-23 Case Western Reserve University 超稳胰岛素类似物在聚合物熔体中的包囊
WO2020106748A1 (en) * 2018-11-19 2020-05-28 Case Western Reserve University Single-chain insulin analogues with poly-alanine c-domain sub-segments
EP3893934B1 (en) 2018-12-11 2025-09-10 Sanofi Insulin conjugates
TWI844709B (zh) 2019-07-31 2024-06-11 美商美國禮來大藥廠 鬆弛素(relaxin)類似物及其使用方法
KR20220112817A (ko) * 2019-12-10 2022-08-11 사노피 설폰아미드 및 폴리펩티드의 콘주게이트를 형성하는 방법
EP4405384A1 (en) 2021-09-20 2024-07-31 Kyon Biotech AG Arginase-insulin fusion protein

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60104069T2 (de) * 2000-10-02 2005-08-25 Yonsei University Einkettige Insulinanaloge
KR100449454B1 (ko) * 2000-10-02 2004-09-21 이현철 단일사슬 인슐린 유도체의 유전자를 포함하는 당뇨병치료용 벡터
BRPI0409600A (pt) * 2003-04-29 2006-04-18 Lilly Co Eli análogo de insulina, composição, método de tratamento de hiperglicemia, e, análogo de pró-insulina
KR100508616B1 (ko) * 2003-06-20 2005-08-17 신항철 염기성 아미노산 첨가를 통한 활성이 증가된 단일사슬 인슐린 아날로그
AU2004295023A1 (en) * 2003-12-03 2005-06-16 Novo Nordisk A/S Single-chain insulin
ES2554773T3 (es) * 2006-10-04 2015-12-23 Case Western Reserve University Insulina y análogos de la insulina resistentes a la fibrilación
CA2722168A1 (en) * 2008-04-22 2009-10-29 Case Western Reserve University Isoform-specific insulin analogues
TWI520745B (zh) * 2009-07-06 2016-02-11 賽諾菲阿凡提斯德意志有限公司 含甲硫胺酸之胰島素製劑
TW201105346A (en) 2009-07-06 2011-02-16 Sanofi Aventis Deutschland Heat-stable and vibration-stable insulin preparations
US8399407B2 (en) 2009-09-17 2013-03-19 Case Western Reserve University Non-standard insulin analogues
AU2012328407A1 (en) * 2011-10-27 2014-05-22 Case Western Reserve University Ultra-concentrated rapid-acting insulin analogue formulations
CA2898730A1 (en) * 2012-01-20 2013-07-25 Case Western Reserve University Glutamic acid-stabilized insulin analogues
CA2886228A1 (en) * 2012-09-26 2014-04-03 Indiana University Research And Technology Corporation Insulin analog dimers

Similar Documents

Publication Publication Date Title
JP2016506366A5 (cg-RX-API-DMAC7.html)
CY2022035I1 (el) Βελτιστοποιηση αντισωματων που δεσμευουν το γονιδιο-3 ενεργοποιησης λεμφοκυτταρων (lag-3), και χρησεις εξ' αυτων
HUE060029T2 (hu) Emberi antitestek, amelyek kötnek limfocita aktivációs gént-3 (LAG-3) és azok felhasználásai
JP2019502892A5 (cg-RX-API-DMAC7.html)
JP2014533241A5 (cg-RX-API-DMAC7.html)
JP2014525291A5 (cg-RX-API-DMAC7.html)
HUE037205T2 (hu) Antitestek, amelyek IL-4-et és/vagy IL-13-at kötnek és alkalmazásaik
HUE063272T2 (hu) Zika-vírus epitópokhoz specifikusan kötõdõ új antitestek és alkalmazásaik
JP2014519854A5 (cg-RX-API-DMAC7.html)
CL2015000420A1 (es) Anticuerpo de unión a gfr alfa 3 (gfra3); ácido nucleico que lo codifica; vector; método para producirlo; composición farmacéutica que lo comprende; y uso para tratar una afección o enfermedad relacionada con gfra3.
MA32980B1 (fr) Proteines de liaison a la myostatine
BRPI0813237A2 (pt) Composto, método para preparar o composto, composição, medicamento, e, uso do composto.
JP2007254881A5 (cg-RX-API-DMAC7.html)
GB201101540D0 (en) Analyzing server copies of client files
JP2018520447A5 (cg-RX-API-DMAC7.html)
JP2015518494A5 (cg-RX-API-DMAC7.html)
JP2016516303A5 (cg-RX-API-DMAC7.html)
JP2014508098A5 (cg-RX-API-DMAC7.html)
JP2013515494A5 (cg-RX-API-DMAC7.html)
JP2016527801A5 (cg-RX-API-DMAC7.html)
JP2011082627A5 (cg-RX-API-DMAC7.html)
JP2014162977A5 (cg-RX-API-DMAC7.html)
JPWO2021108298A5 (cg-RX-API-DMAC7.html)
JP2021502362A5 (cg-RX-API-DMAC7.html)
JP2017528116A5 (cg-RX-API-DMAC7.html)